Malaria remains overwhelmingly concentrated in poorer countries, where progress has slowed and children continue to bear the ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

Warmer weather across the globe is reshaping the landscape of human health. Case in point: dengue fever, a mosquito-borne disease once confined largely to the tropics which often brings flu-like ...

Climate change is having a massive global impact on dengue transmission, accounting for 19% of the current dengue burden, with a potential to spark an additional 40–60% spike by 2050—and by as much as ...

India has approved Takeda's QDENGA, the country's first dengue vaccine. The shot protects against all four dengue virus ...

QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It ...

Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...

Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved ...

Takeda recently announced that India’s Drug Controller General of India (DCGI) has granted marketing authorization for Takeda’s dengue vaccine (TAK-003) for the prevention of dengue disease in ...

Takeda's QDENGA vaccine has been approval in India, becoming the first dengue vaccine authorised for use in the country ...